XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
INVESTMENT IN TNF PHARMACEUTICALS, INC. (Tables)
 9 Months Ended
Jan. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of investment stock and warrants
    
Balance of Series G Preferred Stock as of April 30, 2024  $– 
Purchased   17,410,050 
Change in fair value   (1,642,050)
Balance of Series G Preferred Stock as of January 31, 2025  $15,768,000 

 

Below is a summary of activity for the Preferred Stock Warrants as of January 31, 2025:

      
Balance of Warrant assets as of April 30, 2024  $– 
Purchased   10,985,684 
Change in fair value   (8,123,684)
Balance of Warrant assets as of January 31, 2025  $2,862,000